Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$34.5 - $42.19 $441,600 - $540,032
12,800 Added 80.0%
28,800 $1.21 Million
Q1 2023

May 15, 2023

BUY
$33.32 - $40.98 $469,812 - $577,818
14,100 Added 742.11%
16,000 $569,000
Q4 2022

Feb 14, 2023

SELL
$25.32 - $51.45 $179,772 - $365,295
-7,100 Reduced 78.89%
1,900 $69,000
Q3 2022

Nov 14, 2022

BUY
$46.5 - $79.14 $9,300 - $15,828
200 Added 2.27%
9,000 $424,000

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.